Gain Therapeutics, Inc. (GANX)

Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $52.91 million. The enterprise value is $44.44 million.

Market Cap	52.91M
Enterprise Value	44.44M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

GANX has 29.56 million shares outstanding. The number of shares has increased by 75.99% in one year.

Current Share Class	29.56M
Shares Outstanding	29.56M
Shares Change (YoY)	+75.99%
Shares Change (QoQ)	+3.54%
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	9.52%
Float	28.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.90
P/TBV Ratio	9.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.11.

Current Ratio	2.22
Quick Ratio	1.98
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -290.21% and return on invested capital (ROIC) is -159.82%.

Return on Equity (ROE)	-290.21%
Return on Assets (ROA)	-97.10%
Return on Invested Capital (ROIC)	-159.82%
Return on Capital Employed (ROCE)	-308.58%
Revenue Per Employee	n/a
Profits Per Employee	-$837,082
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GANX has paid $617,450 in taxes.

Income Tax	617,450
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.61% in the last 52 weeks. The beta is 0.11, so GANX's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+35.61%
50-Day Moving Average	1.86
200-Day Moving Average	1.97
Relative Strength Index (RSI)	45.96
Average Volume (20 Days)	219,406

Short Selling Information

The latest short interest is 291,844, so 0.99% of the outstanding shares have been sold short.

Short Interest	291,844
Short Previous Month	290,186
Short % of Shares Out	0.99%
Short % of Float	1.03%
Short Ratio (days to cover)	1.06

Income Statement

Revenue	n/a
Gross Profit	-10.40M
Operating Income	-20.35M
Pretax Income	-21.54M
Net Income	-20.93M
EBITDA	-20.31M
EBIT	-20.35M
Earnings Per Share (EPS)	-$0.82

Balance Sheet

The company has $9.07 million in cash and $606,860 in debt, giving a net cash position of $8.46 million or $0.29 per share.

Cash & Cash Equivalents	9.07M
Total Debt	606,860
Net Cash	8.46M
Net Cash Per Share	$0.29
Equity (Book Value)	5.78M
Book Value Per Share	0.20
Working Capital	6.12M

Cash Flow

In the last 12 months, operating cash flow was -$19.11 million and capital expenditures -$22,493, giving a free cash flow of -$19.13 million.

Operating Cash Flow	-19.11M
Capital Expenditures	-22,493
Free Cash Flow	-19.13M
FCF Per Share	-$0.65

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.99%
Shareholder Yield	-75.99%
Earnings Yield	-39.55%
FCF Yield	-36.16%

Analyst Forecast

The average price target for GANX is $8.20, which is 358.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.20
Price Target Difference	358.10%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2